Skip to main content
. 2023 Dec 29;25(1):467. doi: 10.3390/ijms25010467
AA Allergic asthma
AD Atopic dermatitis
AR Allergic rhinitis
ASX Astaxanthin
ALA Alpha-linolenic acid
AIT Allergen immunotherapy
BALF Bronchoalveolar lavage fluid
β-Hex β-hexosaminidase
BMMCs Bone marrow-derived mast cells
BDMC Bisdemethoxycurcumin
CRS Chronic rhinosinusitis
CRSwNP Chronic rhinosinusitis without nasal polyposis
C3G Cyanidin-3-O-β-glucoside
CA Carnosic acid
COX-2 Cycloocxygenase
DA Drug allergy
DCs Dendritic cells
EPA Eicosapentaenoic acid
FA Food allergy
GM-CSF Granulocyte- monocyte colony-stimulating factor.
GPR43- FFA2 Free fatty acid receptor 2
TXNIP Thioredoxin-interacting protein.
GSH Highly increased glutation
HNEpC Human nasal epithelial cells
iNOS Nitric oxide synthase
IL Interleukin
Ig Immunoglobulin
IgE Inmunoglobulin E
LPS Lipopolysaccharide
MAPK Mitogen-activated protein kinases
MDA Malondialdehyde
MPI Musa paradisiaca inflorescence
NO Nitric oxide.
Nrf2 Nuclear factor Erythroid 2- related factor 2
NFκB Kappa-light-chain-enhancer
NLF Nasal lavage fluid
PA Phthalic anhydride
PI Phosphatidylinositol
PGD Prostaglandin D2
PNE Piper nigrum extract
PCA Passive cutaneous anaphylaxis
PUFA Polyunsaturated fatty acids
PNIF Peak nasal inspiratory flow
OVA Ovalbumin
ROS Allergen-induced reactive oxygen species
RS Resistant starch
SCFAs Short-chain fatty acids
SFN Sulforaphane
TCI Topical calcineurin inhibitors
TRX Thioredoxin
Th2 T helper type 2 cells
TNSS aNsal symptoms
15-HEPE 15-hydroxyeicosapentaenoic acid